In breast cancer, the colocalization of HDAC 6 and ERα in the cytoplasm has been associated with better clinical outcome in tamoxifen-treated patients as well as increased deacetylation of α-tubulin, which led to enhanced cell motility in vitro [13, 14]. Here, ESR1 is linked to breast cancer.